Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Qiagen Rises on Launch of Covid Antigen Test
By Vidhi Choudhary
Nov 12, 2020 1:11 PM EST
PRESS RELEASES
QIAGEN Plans To Resubmit EUA Submission In The U.S. For QIAreach SARS-CoV-2 Antigen Test In The First Quarter Of 2021
By Business Wire
Jan 20, 2021 4:08 PM EST
PRESS RELEASES
QIAGEN Confirms Effectiveness Of Its SARS-CoV-2 PCR Tests In The Face Of Mutations Of The Coronavirus
By Business Wire
Jan 20, 2021 4:05 PM EST
PRESS RELEASES
QIAGEN Announces Appointment Of New Supervisory Board Member
By Business Wire
Jan 8, 2021 7:00 AM EST
PRESS RELEASES
QIAGEN Underlines And Innovates Its Commitment To Sustainability With A EUR 400mn Sustainability-linked Credit Facility
By Business Wire
Dec 17, 2020 4:05 PM EST
PRESS RELEASES
QIAGEN Increases Outlook For 2020 And 2021
By Business Wire
Dec 8, 2020 1:45 AM EST
PRESS RELEASES
QIAGEN To Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread And Control Of COVID-19 Through T-cell Response
By Business Wire
Dec 7, 2020 2:00 AM EST
PRESS RELEASES
QIAGEN Collaborates With BioNTech On Companion Diagnostics Development For HPV-associated Squamous Cell Carcinoma Of The Head And Neck
By Business Wire
Nov 18, 2020 4:05 PM EST
PRESS RELEASES
Leading Diagnostics Companies Join Forces To Establish The Access To Comprehensive Genomic Profiling Coalition (ACGP)
By PR Newswire
Nov 17, 2020 8:00 AM EST
PRESS RELEASES
QIAGEN Launches NeuMoDx Multiplex Test To Complete Range Of SARS-CoV-2 Testing Solutions In Europe And Other Markets
By Business Wire
Nov 16, 2020 4:05 PM EST
INVESTING
Qiagen Rises on Launch of Covid Antigen Test
By Vidhi Choudhary
Nov 12, 2020 1:11 PM EST
PRESS RELEASES
QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour
By Business Wire
Nov 11, 2020 4:05 PM EST
PRESS RELEASES
QIAGEN N.V. To Hold Investor Call On Wednesday, October 28, After Releasing Results For Q3 2020 And First Nine Months Of 2020
By Business Wire
Oct 27, 2020 1:04 PM EDT
PRESS RELEASES
QIAGEN Reports Strong Results For Third Quarter And First Nine Months Of 2020 And Increases Outlook For Full-Year 2020
By Business Wire
Oct 27, 2020 12:59 PM EDT
PRESS RELEASES
QIAGEN Reports Strong Preliminary Results For Third Quarter Of 2020
By Business Wire
Oct 13, 2020 8:45 AM EDT
PRESS RELEASES
QIAGEN Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio Of PCR-based Diagnostic Automation Systems
By Business Wire
Sep 17, 2020 4:05 PM EDT
INVESTING
Qiagen Shares Rise on Plan to Launch Covid Antibody Test
By Vidhi Choudhary
Sep 9, 2020 10:23 AM EDT
PRESS RELEASES
QIAGEN To Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour For SARS-CoV-2 Antigen
By Business Wire
Sep 8, 2020 4:02 PM EDT
STOCKS
Inovio Climbs on Covid-19 Vaccine Deal With Thermo Fisher
By Rob Lenihan
Sep 8, 2020 9:36 AM EDT
Video
AstraZeneca Kicks Off Another Covid-19 Test Trial
Aug 25, 2020 10:08 AM EDT
INVESTING
AstraZeneca Kicks Off Covid-19 Antibody Trials
By M. Corey Goldman
Aug 25, 2020 10:09 AM EDT
PRESS RELEASES
QIAGEN To Launch Easy-to-Use Digital Test In The U.S. For Rapid Detection Of SARS-CoV-2 Antibodies Following FDA Emergency Use Authorization
By Business Wire
Aug 24, 2020 4:02 PM EDT
PRESS RELEASES
QIAGEN Announces New Chairman Of Supervisory Board
By Business Wire
Aug 21, 2020 11:52 AM EDT
PRESS RELEASES
QIAGEN Expands Integrated Coronavirus NGS And Software Solutions To Accelerate COVID-19 Research
By Business Wire
Aug 18, 2020 4:05 PM EDT
INVESTING
Thermo Fisher Exits Planned $13 Billion Takover Of COVID-19 Testing Group Qiagen
By Martin Baccardax
Aug 13, 2020 9:13 AM EDT
